Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol.
暂无分享,去创建一个
E. Braunwald | R. Alexander | G. Mudge | B. Holman | M. Konstam | J. Wynne | G. Williams | W. Colucci | R. Rude
[1] M. Weinberger,et al. Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure. , 1981, The American journal of medicine.
[2] E. Amsterdam,et al. Hemodynamic Effects of Oral Pirbuterol in Chronic Severe Congestive Heart Failure , 1981, Circulation.
[3] E. Braunwald,et al. Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure. , 1980, Annals of internal medicine.
[4] C. Leier,et al. Tolerance to dobutamine after a 72 hour continuous infusion. , 1980, The American journal of medicine.
[5] E. Braunwald,et al. Long-term therapy of heart failure with prazosin: a randomized double blind trial. , 1980, The American journal of cardiology.
[6] R. Lefkowitz. Direct binding studies of adrenergic receptors: biochemical, physiologic, and clinical implications. , 1979, Annals of internal medicine.
[7] M. Pfisterer,et al. Left Ventricular Volumes by Gated Equilibrium Radionuclide Angiography: A New Method , 1979, Circulation.
[8] E. Braunwald,et al. Hemodynamic assessment of amrinone. A new inotropic agent. , 1978, The New England journal of medicine.
[9] P. Insel,et al. Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. , 1978, The New England journal of medicine.
[10] J. A. Thomas,et al. Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.
[11] J. Peuler,et al. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. , 1977, Life sciences.
[12] S. Holgate,et al. β-ADRENERGIC AGONIST RESISTANCE IN NORMAL HUMAN AIRWAYS , 1977, The Lancet.
[13] I. Paterson,et al. Effects of prolonged administration of pirbuterol by mouth in chronic asthma. , 1977, British journal of clinical pharmacology.
[14] T. Chick,et al. Subsensitivity of beta responses during therapy with a long-acting beta-2 preparation. , 1977, The Journal of allergy and clinical immunology.
[15] F. Falkner,et al. Selected ion monitoring assay for the bronchodilator pirbuterol. , 1976, Biomedical mass spectrometry.
[16] M. Caron,et al. Regulation of adenylate cyclase coupled beta-adrenergic receptors. , 1976, Recent progress in hormone research.
[17] R. Lefkowitz,et al. Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. , 1976, The Journal of clinical investigation.
[18] G. Williams,et al. Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. , 1973, The Journal of laboratory and clinical medicine.
[19] C. Mogensen. The glomerular permeability determined by dextran clearance using Sephadex gel filtration. , 1968, Scandinavian journal of clinical and laboratory investigation.